- Evercore ISI 4th Annual HealthCONx Conference on December 1 at 1:25pm ET
- Piper Sandler 33rd Annual Healthcare Conference on December 2 at 1:30pm ET
Nov 29, 2021
SAN RAFAEL, Calif., Nov. 29, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The Company's portfolio consists of several commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release.
Contacts:
|
|
Investors
| Media
|
Traci McCarty
| Debra Charlesworth
|
BioMarin Pharmaceutical Inc.
| BioMarin Pharmaceutical Inc.
|
(415) 455-7558
| (415) 455-7451
|
SOURCE BioMarin Pharmaceutical Inc.
